DM-Flow/Duo™ are the two (2) most popular devices and are part of our Diabetic Amputation Prevention Program (DAAP) that focuses on the lower extremities of patients living with diabetes. These modalities combined have a total of five (5) Medicare reimbursable codes that average just under $500 per patient.

OFTEN OVERLOOKED AS MORTALITY RISKS, Distal Symmetric Polyneuropathy (DSPN), a glove and stocking distribution, is the most common form of Diabetic Peripheral Neuropathy (DPN) and is recognized as the most troublesome complication of diabetes mellitus. DPN is the most common form of neuropathy in the developed countries of the world, it accounts for more hospitalizations than all the other diabetic complications combined, and is responsible for 50-75% of non-traumatic amputations. 

Diabetic Neuropathy Accounts for More Hospitalizations than All the Other Diabetic Complications Combined.

Peripheral Arterial Disease (PAD) reduces blood flow to the feet and legs and can cause pain in the feet and legs which may lead to tissue death (gangrene). People with diabetes and a history of smoking are most at risk of developing peripheral artery disease. Studies say at least 1 in 5 elderly people suffer from hardened arteries reducing blood flow to the limbs. 

Diabetic Neuropathy Device™ www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies, and Measures Peripheral Neuropathy. 

TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow.